DexCom Aktie

127,12USD -0,23USD -0,18%
DexCom für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: A0D9T1 / ISIN: US2521311074
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 98,42
The Vanguard Group, Inc. 11,53
Vanguard Group, Inc. (Subfiler) 11,13
State Street Corp. 4,21
Baillie Gifford & Co. 4,07
BlackRock Fund Advisors 3,58
Capital Research & Management Co. (Global Investors) 3,49
Vanguard Total Stock Market ETF 3,15
Sands Capital Management LLC 2,83
Vanguard 500 Index Fund 2,54
Geode Capital Management LLC 2,38
BlackRock Institutional Trust Co. NA 2,20
Vanguard Mid Cap Index Fund 2,18
Capital Research & Management Co. (World Investors) 2,09
Invesco QQQ Trust 1,88

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 5 200 6 400 6 300 7 600 9 600
Umsatz pro Mitarbeiter in Mio. EUR 0,28 0,30 0,39 0,38 0,38

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 1 969 3 425 3 684 3 669 4 426
Summe Anlagevermögen 2 043 3 666 4 130 4 277 4 663
Summe Aktiva 2 395 4 383 4 864 5 392 6 265

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 1 160 1 840 1 879 2 145 2 594
Summe Fremdkapital 1 512 2 556 2 612 3 260 4 196
Summe Eigenkapital 883 1 827 2 252 2 132 2 069
Summe Passiva 2 395 4 383 4 864 5 392 6 265

Adresse

6340 Sequence Drive, 92121 San Diego
Telefon +1 (858) 200-0200
Internet http://www.dexcom.com

Management

Andrew K. Balo
EVP-Global Medical Affairs, Access & Evidence
Barbara E. Kahn
Independent Director
Barry J. Regan
Executive Vice President-Global Operations
Bridgette P. Heller
Independent Director
Donald M. Abbey
Executive VP-IT Quality & Regulatory Affairs
Eric J. Topol
Independent Director
Girish Naganathan
Chief Technology Officer & Executive VP
Jacob S. Leach
Chief Operating Officer & Executive Vice President
Jereme M Sylvain
Chief Financial Officer & Executive Vice President
Karen M. Dahut
Independent Director
Kevin Ronald Sayer
Chairman, President & Chief Executive Officer
Kyle J. Malady
Independent Director
Mark G. Foletta
Lead Independent Director
Matt V. Dolan
Executive VP-Strategy & Corporate Development
Michael Jon Brown
Chief Legal Officer & Executive Vice President
Nicholas Augustinos
Independent Director
Paul R. Flynn
Executive Vice President-Global Revenue
Richard Alexander Collins
Independent Director
Rimma Driscoll
Independent Director
Sadie M Stern
Chief Human Resources Officer & Executive VP
Sean Christensen
Vice President-Finance & Investor Relations
Shelly R. Selvaraj
Chief Information Officer & Senior Vice President
Steven R. Altman
Independent Director
Steven Robert Pacelli
Executive VP & Managing Director-Dexcom Ventures
Teri Lawver
Chief Commercial Officer & Executive VP